| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | 1 | — | — | — | 1 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 0.12 |
—
—
—
|
| 2025 | 0.16 |
—
—
—
—
|
| 2024 | 0.16 |
—
—
—
—
|
| 2023 | 0.16 |
—
—
—
—
|
| 2022 | 0.16 |
—
—
—
—
|
| 2021 | 0.16 |
—
—
—
—
|
| 2020 | 0.16 |
—
—
—
—
|
| 2019 | 0.16 |
—
—
—
—
|
| 2018 | 0.16 |
—
—
—
—
|
| 2017 | 0.16 |
—
—
—
—
|
| 2016 | 0.16 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 163.88 | 94.33 | 82.30 | 107.54 |
| Receivables | 78.57 | 77.65 | 88.10 | 92.16 |
| Inventory | 60.03 | 52.31 | 52.85 | 59.59 |
| Other | 16.87 | 17.88 | 29.46 | 27.10 |
| 319.35 | 242.17 | 252.71 | 286.38 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 43.50 | 42.63 | 48.22 | 49.96 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 97.04 | 98.46 | 109.69 | 109.79 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 139.23 | 144.78 | — | — |
—
|
| ’25 | 125.77 | 135.31 | 142.97 | 137.27 |
541.32
|
| ’24 | 125.75 | 130.16 | 132.38 | 126.46 |
514.76
|
| ’23 | 145.99 | 145.18 | 134.55 | 124.69 |
550.42
|
| ’22 | 147.70 | 144.98 | 151.91 | 142.28 |
586.87
|
| ’21 | 128.43 | 129.59 | 122.38 | 132.53 |
512.93
|
| ’20 | 103.08 | 84.20 | 113.78 | 123.02 |
424.07
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 17.30 | 33.44 | — | — |
—
|
| ’25 | 15.52 | 28.35 | 29.02 | 29.21 |
102.11
|
| ’24 | 18.31 | 19.63 | 35.40 | 24.91 |
98.24
|
| ’23 | 11.19 | 23.42 | 22.14 | 32.07 |
88.81
|
| ’22 | 19.29 | 16.07 | 60.39 | 25.46 |
121.20
|
| ’21 | 20.11 | 18.68 | 21.33 | 26.02 |
86.14
|
| ’20 | 11.93 | 11.80 | 25.57 | 27.49 |
76.78
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 12.30 | 28.86 | — | — |
—
|
| ’25 | 11.05 | 25.07 | 24.23 | 26.02 |
86.37
|
| ’24 | 14.28 | 14.99 | 31.52 | 18.81 |
79.60
|
| ’23 | 6.65 | 19.47 | 19.39 | 28.57 |
74.07
|
| ’22 | 15.89 | 12.48 | 58.12 | 20.39 |
106.86
|
| ’21 | 18.47 | 16.34 | 17.16 | 18.52 |
70.50
|
| ’20 | 7.36 | 9.12 | 22.38 | 23.07 |
61.93
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.59 | 0.66 | — | — |
—
|
| ’25 | 0.44 | 0.62 | 0.46 | 0.67 |
2.19
|
| ’24 | 0.36 | 0.48 | 0.61 | 0.45 |
1.89
|
| ’23 | 0.58 | 0.41 | 0.44 | 0.49 |
1.92
|
| ’22 | 0.63 | 0.39 | 0.37 | 0.47 |
1.85
|
| ’21 | 0.37 | 0.03 | (1.97) | 0.28 |
(1.30)
|
| ’20 | 0.12 | 0.15 | 0.34 | 0.46 |
1.06
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.07 | 35.50 | 40.09 | 34.02 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 45.22 | 49.59 | 59.68 | 53.48 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,209 | 4,081 | 3,549 | 3,492 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.14 | 0.13 | 0.15 | 0.16 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 586.87 | 550.42 | 514.76 | 541.32 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.87% | 34.68% | 36.44% | 38.43% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 80.74 | 75.15 | 68.58 | 83.77 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.76% | 13.65% | 13.32% | 15.48% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.58 | 60.53 | 55.47 | 65.32 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.75 | 28.71 | 30.92 | 34.54 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.36 | 17.55 | 16.93 | 18.34 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.86 | 1.93 | 1.91 | 2.21 | ‡‡‡‡‡ | ‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.79 | 2.83 | 3.23 | 3.46 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.45) | (0.47) | (0.61) | (0.53) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.34 | 2.36 | 2.62 | 2.93 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.84 | 16.80 | 17.37 | 18.70 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.97 | 31.36 | 30.41 | 29.51 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 21.57 | 22.62 | 27.61 | 19.31 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.19 | 2.49 | 3.11 | 2.34 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.53 | 2.60 | 3.04 | 2.29 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.07 | 2.32 | 3.12 | 2.30 | ‡‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.35 | 17.24 | 20.17 | 14.41 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 121.20 | 88.81 | 98.24 | 102.11 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (14.33) | (14.74) | (18.64) | (15.73) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 106.86 | 74.07 | 79.60 | 86.37 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 213.23 | 222.31 | 143.71 | 143.02 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 87.61 | 67.50 | 92.30 | 57.50 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (69.30) | (96.38) | (2.03) | (24.79) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 506.22 | 526.82 | 528.21 | 551.79 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.43% | 8.13% | 7.36% | 8.54% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.30% | 10.90% | 8.46% | 9.80% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.29% | 11.72% | 10.52% | 12.10% | ‡‡‡‡‡ | — | — |
ROE
|
CTS Corporation has demonstrated resilience in the volatile electronics components sector, with revenue compounding at 4% annually from $397 million in 2016 to $516 million in 2024, despite COVID disruptions and recent dips tied to automotive inventory corrections. Fundamentals are strengthening—gross margins hit 36.7% in 2024, EBT margins reached 13.8%, and free cash flow per share stood at $2.65—bolstered by operational efficiency (revenue per employee at $145,329) and a fortress balance sheet featuring negligible net debt and 67% equity growth. Yet, shares trade 6% above unanimous analyst targets, with forward P/E at 22x and premiums in PS and EV/Sales ratios signaling potential overvaluation amid a recent CFO insider sale and no buys.
Projections offer optimism: revenue forecasted to rise 5% to $541 million in 2025 and 4% to $566 million in 2026, driving EPS from $1.91 to $2.41 (26% cumulative gain) and net income to $71 million, fueled by EV adoption and 5G tailwinds. ROE at 11% and ROIC at 8.6% align with peers, while capex investments promise further productivity gains.
Risks include U.S.-China tensions, EV slowdowns, and margin pressures, echoing past cycles where multiples compressed post-euphoria. With historical dips below 20x P/E delivering outsized returns, CTS suits patient holders—read the full analysis for quantitative models and probabilistic scenarios on the 2026 inflection.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.